1. Gene Patents

   • Karen P. Mann

   Current Opinion 16 August 2012 Pages: 137 - 140

2. Innovative Diagnostic Technologies and Their Significance for Personalized Medicine

   • Kewal K. Jain

   Current Opinion 16 August 2012 Pages: 141 - 147

   

3. Identification of Cancer Autoantigens in Serum

   • J. Ignacio Casal
   • Rodrigo Barderas

   Leading Article 16 August 2012 Pages: 149 - 154

   

4. Programmed Cell Death 4 (PDCD4) Enhances the Sensitivity of Gastric Cancer Cells to TRAIL-Induced Apoptosis by Inhibiting the PI3K/Akt Signaling Pathway

   • Wei-Qiang Wang
   • Hao Zhang
   • Dian-Chun Fang

   Original Research Article 16 August 2012 Pages: 155 - 161

   

5. Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients

   • Mateusz Bujko
   • Paulina Kober
   • Janusz A. Siedlecki

   Original Research Article 16 August 2012 Pages: 163 - 169

   

6. Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes

   • Francina Fonseca
   • Mònica Gratacòs
   • Marta Torrens

   Original Research Article 16 August 2012 Pages: 171 - 178

   

7. Clinical Characteristics and PTPN22 1858C/T Variant Analysis in Jordanian Arab Vitiligo Patients

   • Asem Alkhateeb
   • Firas Qarqaz
   • Tasnim Al Rashaideh

   Original Research Article 16 August 2012 Pages: 179 - 184

   

8. Melting Point Assay for the JAK2 V617F Mutation, Comparison with Amplification Refractory Mutation System (ARMS) in Diagnostic Samples, and Implications for Daily Routine

   • Sebastian Ochsenreither
   • Mark Reinwald
   • Thomas Burmeister

   Technology Report 16 August 2012 Pages: 185 - 190

   

9. C-Reactive Protein as a Clinically Useful Biomarker of Metastasis of Renal Cell Carcinoma

   • Timothy V. Johnson
   • Andrew N. Young
   • Viraj A. Master

   Case Report 16 August 2012 Pages: 191 - 193

   

10. From the Literature

    News 16 August 2012 Pages: 195 - 203